Join
Live feed
·
PRReleasevia Quantisnow
Delcath Systems Inc. logo

Delcath Systems, Inc. Announces FDA Approval of HEPZATO KIT™ for the Treatment of Adult Patients with Unresectable Hepatic-Dominant Metastatic Uveal Melanoma

ByQuantisnow·Wall Street's wire, on your screen.
DCTH· Delcath Systems Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track DCTH (Delcath Systems Inc.) and more on Quantisnow.